In the present study we describe a novel secreted protein, named C12ORF39 (chromosome 12 open-reading framework 39), which contains a typical amidation/proteolytic processing signal (Gly-Arg-Arg motif). Interestingly, C12ORF39 protein is not hydrolysed, but is a full-length protein without signal peptides. Western blotting indicated that c-Myc-tagged C12ORF39 is secreted into culture medium in transfected HeLa cells. Quantitative RT-PCR (reverse transcription-PCR) analysis revealed that c12orf39 is mainly expressed in placenta and brain. Immunohistochemistry on formalin-fixed paraffin-embedded human term placenta using a rabbit antibody against human C12ORF39 demonstrated that the protein was localized extracellularly, surrounding the trophoblastic cells. In addition, C12ORF39 secretion could be blocked by brefeldin A, suggesting that the secretion of C12ORF39 is dependent on the Golgi apparatus. Furthermore, laser-scanning confocal microscopy also confirmed that the C12ORF39 protein co-localized with the Golgi apparatus. Taken together, although C12ORF39 is not a secreted small peptide, it can also be secreted to play a role in the biological functions of the placenta.
INTRODUCTION
Proteins secreted by cells into the extracellular milieu, sometimes collectively referred to as the secretome, are potential mediators of cell survival, proliferation, differentiation and fusion [1] . In humans, secreted proteins account for approximately one-tenth of the human proteome, including major factors of signalling pathways, blood coagulation, immune defence and carcinogenesis, as well as digestive enzymes and components of the extracellular matrix [2] . Secreted and cell-surface proteins are fundamental to intercellular communication of multicellular organisms. These proteins are considered to be ideal targets for protein therapeutics due to their extracellular accessibility [3] [4] [5] [6] . Previous studies from our laboratory have identified and characterized some secreted proteins based on bioinformatic tools and human genomic information [7] [8] [9] [10] [11] [12] . Among these secreted proteins, hZG16 (human zymogen granule protein 16), down-regulated in hepatocellular carcinoma, functions in the secretion of glycoproteins [10] . Another protein, hOLFML1 (human olfactomedin-like protein 1), may play a significant role in the regulation of cancer cell proliferation [12] .
Many bioactive peptide hormones, which are synthesized as larger precursor molecules, usually undergo several posttranslational modification processes [13] . Amidation is the last post-translational activation step in the biosynthetic pathway of many peptide hormones [14] . More than half of the known peptide hormones are α-amidated and this structural feature is essential for receptor recognition, signal transduction and biological function [15] . Peptide α-amidation is catalysed by PAM (peptidylglycine α-amidating mono-oxygenase) [15] , which can recognize the typical amidation processing signal Gly-Arg-Arg motif (glycine followed by two basic residues) [16] . Gastrin, a well-known peptide hormone, is normally produced by endocrine cells located in the gastric antrum [17] . Gastrin is translated as a 101 amino acid precursor protein and undergoes sequential processing to the final 17 amino acid amidated end-product gastrin 17 [18] . Increasing evidence supports the hypothesis that gastrin is not only a hormone responsible for gastric acid secretion, but may also play an important role in carcinogenesis [18] . The peptide obestatin was previously identified by bioinformatic searches for typical amidation processing signals of pre-propeptides of known peptide hormones [19] .
In the present study we report that human C12ORF39 (chromosome 12 open-reading framework 39) protein contains a typical amidation processing signal among our screened hypothetical secreted protein set. Unexpectedly, the amidation processing signal of C12ORF39 has not been hydrolysed and amidated to be secreted as a peptide. However, full-length C12ORF39 still could be secreted into the medium through a classical secretion pathway and may play a role in the placenta. This is the first report that a protein with a typical amidation processing signal and its conserved flanking peptide sequence could be secreted without hydrolysis and amidation processes.
MATERIALS AND METHODS

Bioinformatic analysis of C12ORF39
The online software SignalP v3.0 (http://www.cbs.dtu.dk/ services/SignalP/) [20] , PSORT II (http://psort.ims.u-tokyo. ac.jp/) and SOSUI (http://bp.nuap.nagoya-u.ac.jp/sosui/) were used to predict novel secreted proteins from the public protein databases. Bioinformatic prediction was performed as described previously [7] . The secondary structure wase predicted using the PSIPRED server (http://bioinf.cs.ucl.ac.uk/psipred/) [21] . The sequence alignment was carried out using ClustalW (http:// www.ebi.ac.uk/clustalw) and visualized with Genedoc software (http://www.nrbsc.org/gfx/genedoc/). N-glycosylation sites were predicted on the NetNglyc server using the artificial neural networks algorithm (http://www.cbs.dtu.dk/services/NetNGlyc/). Hydrophobicity and antigenicity analyses were performed using CLC combined workbench software V3.0 (CLC bio) by the Kyte-Doolittle [22] and Kolaskar [23] methods respectively.
Cloning of c12orf39
The entire protein-coding sequence of c12orf39 was amplified from mixed multiple tissue RNA (Clontech) by RT-PCR (reverse transcription-PCR) using c12orf39-3.1B primers. The PCR reaction was performed under the following conditions: 94
• C for 5 min, 35 cycles of 94
• C for 30 s, 58
• C for 30 s and 72
• C for 40 s, and a final extension at 72
• C for 5 min. The purified PCR product was cloned into the mammalian expression vector pcDNA3.1B-Myc-His (Invitrogen) at the XhoI and EcoRI sites. To construct a plasmid expressing c12orf39 in Escherichia coli, the C-terminal sequence of c12orf39 was subcloned into the pGEX-4T-1 vector (GE Healthcare) at the EcoRI and XhoI sites with c12orf39-GST (glutathione transferase)-1 primers. The sequences of all of the primers and the product sizes are shown in Table 1 .
Cell culture, transfection and Western blot analysis
COS-7 and HeLa cells were cultured in DMEM (Dulbecco's modified Eagle's medium) supplemented with 10% (v/v) fetal . The cells were lysed with sample loading buffer. The purified culture medium and cell lysate were then subjected to SDS/PAGE (15% or 20% gels) and transferred on to nitrocellulose membranes (Amersham Biosciences). Immunoblotting was carried out with a mouse monoclonal antibody against c-Myc (Santa Cruz Biotechnology) at 4
• C overnight, followed by incubation with an IRDye800-conjugated donkey anti-mouse IgG antibody at 20
• C for 1 h (Rockland Immunochemicals). Immunoreactive proteins were visualized using an Odyssey infrared imaging system (LI-COR Biosciences).
Immunofluorescence staining
HeLa cells grown on glass coverslips were transfected with the construct C12ORF39-Myc-His. At 48 h post-transfection, cells were washed twice with PBS, then fixed in 4% (w/v) paraformaldehyde at 4
• C for 30 min, followed by permeabilization in 0.1% Triton X-100 for 5 min at 4
• C. The fixed cells were then blocked with 10% (v/v) horse serum for 2 h at room temperature (20 • C), and incubated with a monoclonal antibody against c-Myc (1:200 dilution) at 4
• C overnight, followed by incubation with an Alexa Fluor ® 488-conjugated anti-mouse IgG antibody at 20
• C for 1 h (1:500 dilution) (Molecular Probes). Slides were embedded in an anti-fade aqueous mounting medium containing 1 μg/ml DAPI (4 ,6-diamidino-2-phenylindole) (Sigma) and then evaluated and photographed on an Olympus BX60 fluorescence microscope equipped with an Olympus DP70 digital camera.
Polyclonal antibody production
The C12ORF39-GST (36-116 amino acids) fusion protein was expressed in E. coli BL21 (DE3) cells (Stratagene). The bacteria were incubated at 37
• C until the attenuance (D) at 600 nm reached 0.5, then the cells were shifted to 28
• C, and supplemented with 0.1 mM IPTG (isopropyl β-D-thiogalactoside) for 3 h to induce the expression of C12ORF39-GST. After extensive sonication, the soluble fusion protein was purified using Glutathione Sepharose 4B affinity columns (Amersham Biosciences). New Zealand white rabbits (Shanghai Laboratory Animal Centre, Chinese Academy of Sciences) were then immunized with the purified GST fusion protein. After 2 months of standard immunization, rabbits were anaesthetized with ether and blood samples were collected. All experimental protocols complied with the National Institutes of Health Guidelines for the Use and Care of Laboratory Animals (NIH publication 85-23, revised 1985) and were approved by The Academy of Sciences of China. The rabbit antisera were affinity purified sequentially through a Protein-G-Sepharose 4 FF column (Amersham Biosiences) and an immobilized GST column (Pierce) according to the manufacturers' instructions.
Quantitative real-time RT-PCR analysis
Human multiple tissue total RNA was obtained from Clontech. The RNA concentration and quality was determined using a NanoDrop spectrophotometer (NanoDrop Technologies). cDNA was synthesized using MMLV (Moloney-murine-leukaemia virus) reverse transcriptase (Promega) by priming of random hexamers, and then the obtained cDNA was used as a template in subsequent real-time PCR reactions. Quantitative real-time PCR amplifications were performed in a Thermal Cycler Dice TP800 Real-Time system (TaKaRa) using SYBR Premix Ex Taq (TaKaRa) according to the manufacturer's instructions. The quantity of c12orf39 mRNA in each sample was normalized using the C t (threshold cycle) value obtained for the β-actin mRNA amplifications. To minimize the background of products amplified from genomic DNA, these primers were designed to amplify two different exons. The sequences of the primer sets for c12orf39 and β-actin mRNAs and the product sizes obtained by PCR are shown in Table 1 .
Immunohistochemistry analysis
Human term placental tissues were fixed in 4% (w/v) buffered formalin for 24 h, dehydrated and embedded in paraffin. Tissue sections (5 μm) were deparaffinized and rehydrated with PBS. The endogenous peroxidase activity was inactivated by incubation in 3% (v/v) hydrogen peroxide at 20
• C for 15 min. After non-specific binding sites were blocked using protein block buffer [PBS containing 10% (v/v) normal goat serum] for 20 min, the samples were incubated sequentially with a primary antibody (anti-C12ORF39, 1:100 dilution) at 4
• C overnight and with an anti-rabbit EnVision secondary antibody (DAKO) at 20
• C for 1 h. The signals were detected with a DAB (diaminobenzidine) substrate kit (DAKO). Pre-immune serum was used as a negative control. All sections were then counterstained with haematoxylin to identify cell nuclei.
Laser-scanning confocal microscopy
HeLa cells were treated essentially as described previously [12] , except that the pEYFP-Golgi plasmid (Clontech) encoding a YFP (yellow fluorescent protein) fusion protein that specifically targets the trans-medial regions of the Golgi apparatus was used as a marker to visualize the Golgi complex. c12orf39-3.1B, hGH (human growth hormone)-3.1 or TRX (thioredoxin)-3.1 plasmids were co-transfected into HeLa cells with the pEYFPGolgi plasmid respectively. Mouse anti-c-Myc antibody (1:200 dilution; Santa Cruz Biotechnology), rabbit anti-C12ORF39 antibody (1:100), rabbit anti-calnexin antibody (Stressgen), Cy3 (indocarbocyanine)-conjugated goat anti-rabbit IgG antibody (1:500 dilution; Jackson Immunoresearch) and Alexa Fluor ® 633-conjugated goat anti-mouse antibody (1:500 dilution; Molecular Probes) were employed. The slides were analysed using a laser-scanning confocal microscope (LSM510 META, Zeiss) equipped with a Zeiss AxioCam HR-cooled CCD (chargecoupled device) camera and a 40× oil-immersion objective.
BFA (brefeldin A) treatment
HeLa and COS-7 cells were transfected with c12orf39-3.1B, hGH-3.1 and TRX-3.1 plasmids respectively. At 24 h posttransfection, cells treated with 1 μg/ml BFA (Sigma) diluted in complete DMEM at 37
• C. Cells were treated with BFA for 5 h in the laser-scanning confocal microscopy assay. For Western blotting, cells were treated with BFA for 24 h, and then the cells were lysed with sample loading buffer and the culture medium of the transfected COS-7 cells was purified with Ni-NTA agarose, then the cell lysate and cell medium were separated by SDS/PAGE (15% gels) and detected by Western blotting.
RESULTS
Identification of C12ORF39, a protein containing an amidation processing signal
The prediction of novel human secreted proteins was carried out using bioinformatics tools in our laboratory using public human protein databases, and some putative secreted proteins were screened and confirmed by experiments [7] [8] [9] [10] [11] [12] . In the present study, the human C12ORF39 protein has also been identified as a potential novel secreted protein by the same strategy. The C12orf39 gene is located on human chromosome 12p12 with 6 exons and 5 introns, encoding a protein of 116 amino acids (see Figure 1A ). The online SignalP and SOSUI software packages indicated that the C12ORF39 protein had a significant signal peptide in its N-terminus (amino acids 1-21) ( Figure 1B ) and the PSORT II program predicted that the possibility of extracellular localization was 66.7%, significantly higher than those of mitochondrial (22.2%) and nuclear (11.1%) localization. In addition, hydrophobicity analysis revealed that most of the sequence of C12ORF39 was hydrophilic and soluble, except for the N-terminal transmembrane signal peptide ( Figure 1C) . Moreover, the primary structure of C12ORF39 protein contained a typical amidation/proteolytic processing signal (Gly-Arg-Arg, a motif containing glycine and followed two basic amino acids), a common feature of bioactive and secreted peptide hormones. Together, these bioinformatic analyses suggested that C12ORF39 may be a secreted peptide.
Other than human c12orf39, its homologues in other organisms were also identified by searching against the databases deposited in the NCBI (National Center for Biotechnology Information) website. All of these protein sequences are aligned in and Mus musculus (mouse, XP_913145.2) sequences. Although full-length C12ORF39 was not significantly similar to its orthologues from primates (chimpanzee, 68% identity at the amino acid level) and mammals (e.g. mouse and rat, 66% and 54% identity at the amino acid level respectively), the typical amidation/proteolytic processing signal sequences and its flanking N-terminal 24 amino acid sequences were highly conserved (95% identity), suggesting that the 24 amino acid sequence was very important for the gene during evolution and also that a secreted peptide may have existed before the typical amidation signal sequence.
C12ORF39 is a secreted protein, but not an amidated peptide
To examine whether C12ORF39 is secreted into extracellular medium, the plasmid pcDNA3.1-c12orf39-Myc-His encoding the c-Myc-tagged C12ORF39 and hGH (as a positive control) plasmid were transiently transfected into COS-7 cells. The culture medium was collected 48 h after cell transfection, and Western blotting was then carried out using an anti-c-Myc antibody. As a result, c-Myc-tagged C12ORF39 could be detected in culture medium (Figure 2A ), indicating that C12ORF39 can be exported into the extracellular medium, in accordance with our prediction. The 15 kDa band is consistent with the predicted size of the full-length (except for the signal peptide sequence) c-Myc-and His-tagged C12ORF39. The 18 kDa band is larger than the predicted band. Bioinformatic analysis showed that C12ORF39 contains a potential N-glycosylation site (amino acid residue 23), suggesting that the increased size may result from N-glycosylation. Consistent with the above findings, immunofluorescence demonstrated that C12ORF39 was localized exclusively to the cytoplasm, providing additional evidence that C12ORF39 is a secreted protein ( Figure 2B ). Since the c-Myc antibody could not be used for the detection of hydrolysed and amidated peptides, we produced an antibody against C12ORF39. For this, we predicted the antigenicity of C12ORF39 using the CLC combined workbench software to check if it is capable of immunizing animals. As shown in Figure 3(A) , two sequence fragments (amino acids 35-50 and 75-95) are suitable for use as antigens. Subsequently, we subcloned the 36-116 amino acid sequence of C12ORF39 (covering the hypothetical secreted peptide region) into the pGEX-4T-1 vector to express as a protein in E. coli to obtain a GST-fusion protein.
After purification, we used the fusion protein as an antigen to immunize New Zealand rabbits ( Figure 3B ). Finally, after two months standard immunization, we obtained and purified the rabbit antibody against C12ORF39. Both the antibodies against C12ORF39 and c-Myc were employed to test whether there were secreted peptides in the c12orf39-3.1B-transfected cell medium.
Unexpectedly, there were only two full-length C12ORF39 protein bands, but not the hypothetical hydrolysed peptide bands and the other processed bands ( Figure 3C ). These analyses support the notion that C12ORF39 is secreted into the extracellular medium largely as a full-length protein, and not as a hydrolysed and amidated peptide.
C12orf39 is primarily expressed in the placenta
To investigate whether endogenous C12ORF39 is expressed in cells, we examined the C12ORF39 protein in cell lines using Western blotting. We found that C12ORF39 is expressed in several cell lines, especially in HEK-293 cells (human embryonic kidney cells) and HeLa cells ( Figure 4A ). We next determined in which tissues c12orf39 was expressed using quantitative realtime RT-PCR. Interestingly, the expression pattern of c12orf39 was relatively specific in certain tissues. C12orf39 mRNA was very highly expressed in placenta and brain, moderately expressed in kidney and testis, and very weakly expressed in pancreas, lung, ovary, oesophagus, colon, prostate, heart, spleen, liver and stomach ( Figure 4B ). Since c12orf39 was highly expressed in the placenta, we further focused on the placenta to confirm that the C12ORF39 protein was really expressed in this tissue by using immunohistochemical staining. As shown in Figure 5 (A), consistent with the RT-PCR assay result, most of the endogenous C12ORF39 protein was expressed extracellularly surrounding the villous trophoblastic cells. In contrast, there was no such signal observed when the pre-immune antibody was used as a negative control ( Figure 5B ).
C12ORF39 protein is secreted via the classical ER (endoplasmic reticulum)/Golgi-dependent pathway
After showing that C12ORF39 is a secreted protein, we further investigated via which pathway C12ORF39 was secreted into the culture medium. Generally, a secreted protein with a signal peptide is transported from the ER to the Golgi apparatus, secretory vacuole and then delivered to the outside of the cell. To determine if the secretion of C12ORF39 protein indeed goes through the Golgi apparatus, the plasmid pEYFP-Golgi was transfected into HeLa cells to indicate the sites of the Golgi apparatus. As a result, endogenous C12ORF39 protein showed a good co-localization with the Golgi apparatus ( Figure 6A ), indicating that C12ORF39 may be a classical secreted protein. To confirm that C12ORF39 is secreted via the classical ER/Golgidependent pathway, pEYFP-Golgi plasmid was co-transfected into HeLa cells with C12ORF39-3.1, hGH-3.1 and TRX-3.1 respectively. Moreover, an antibody against calnexin (an ERlocalized protein) was employed to visualize the ER. As shown in Figure 6 (B), C12ORF39 significantly co-localized with the Golgi apparatus and the ER; in addition, part of the pool of the C12ORF39 protein exists outside of the ER in the cytoplasm, which resembles the distribution of the well-documented classical secreted protein, growth hormone ( Figure 6C ). To further verify that the Golgi is indeed involved in the secretion of C12ORF39, we treated transfected HeLa cells with BFA, an inhibitor of ER-to-Golgi protein transport. We found that 5 h post-treatment with BFA, all of the C12ORF39 protein, as well as growth hormone, was present only inside the ER (Figures 6B  and 6C ). In contrast, after BFA treatment, TRX (a well-known non-classical secreted protein) still did not co-localize with the Golgi and most of the TRX was present outside of the ER (Figure 6D , TRX). These observations indicate that BFA inhibits the transport of C12ORF39 from the ER to the Golgi apparatus.
In addition, Western blotting demonstrated that the secretion of C12ORF39 protein and growth hormone respectively were completely blocked by BFA, whereas the secretion of TRX was not obviously affected by BFA (Figure 7 ). These results strongly suggest that C12ORF39 is a classical secreted protein.
DISCUSSION
In the present study, we isolated and characterized a new human secreted protein, C12ORF39, through a combination of computational and functional screenings. This is the first study on the characterization of C12ORF39 and its orthologues. C12ORF39 could be secreted into the medium in a classical ER/Golgi-dependent manner, which was consistent with our prediction. Although the whole protein sequence of C12ORF39 is not significantly conserved, the typical amidation/proteolytic processing signal GlyArg-Arg and its flanking sequences are highly conserved. Previous studies have shown that novel peptide hormones are very difficult to identify, because most of the known peptide precursor proteins are not conserved, only particular hormone peptides or short sequence motifs are conserved [24] . All of these results are reminiscent of the peptide hormone obestatin [19] . Obestatin is a peptide hormone which is 23 amino acids in length. Only the region which encodes the 23 amino acid peptide sequence and a flanking Gly-Arg-Arg motif at the C-terminus are highly conserved. Surprisingly, we found only the full-length form of the C12ORF39 protein, rather than the hydrolysed and amidated peptides. Therefore our results indicate, to our knowledge for the first time, that a highly conserved peptide sequence plus a typical amidation/proteolytic processing signal sequence do not definitely mean that a protein should be hydrolysed and amidated as a secreted peptide to play a physiological role. Nevertheless, our results provide clear evidence to support the prediction that C12ORF39 is a secreted protein, suggesting that C12ORF39 may function as a whole protein, and not necessarily as a hydrolytic peptide. However, the present study does not exclude the following two possibilities. First, although hydrolytic peptides indeed exist in the culture medium, the quantity of these peptides present was too low to be detected by Western blotting. Secondly, despite the existence of a small quantity of very small peptides, our conventional protein electrophoretic methods may not have detected these peptides [25] . It is well known that human placenta and brain are active secretory tissues [26, 27] . Our quantitative real-time RT-PCR results showed that c12orf39 was mainly expressed in these two kinds of tissues, especially in placenta, suggesting that c12orf39 may function in these active secretory tissues. The immunohistochemical staining demonstrated that C12ORF39 protein exists extracellularly in the villous trophoblast, where trophoblastic cells exert a crucial role in fetomaternal exchanges and possess endocrine activity, releasing hormones involved in the homoeostasis of pregnancy [28] . Additionally, a more recent study has revealed that the trophoblast regulates the secretion of the placental growth hormone and relates to the development of placenta . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . The secretion of C12ORF39 protein was blocked by BFA COS-7 cells were transfected with c12orf39-3.1, hGH-3.1 and TRX-3.1 plasmids respectively. At 24 h post-transfection, 1 μg/ml BFA was added into the transfected cell culture medium for 24 h, then the cell lysate was subjected to Western blotting using an anti-c-Myc antibody. hGH and TRX were used as positive and negative controls respectively. [29] . All of these findings suggest that C12ORF39 may play a role in the biological functions of the trophoblast. However, whether C12ORF39 is involved in regulation of placenta development needs to be further investigated.
